Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 11/26 04:00:01 pm
115.39 USD   +1.05%
6d ago NASDAQ 100 MOVERS : Vrtx, adsk
11/20 VERTEX PHARMACEUTICALS : to Present at Deutsche Bank BioFEST on December 2
11/20 NASDAQ 100 MOVERS : Gmcr, dltr
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/20/2014 11/21/2014 11/24/2014 11/25/2014 11/26/2014 Date
112.89(c) 111.4(c) 113.8(c) 114.19(c) 115.39(c) Last
2 557 395 1 300 131 1 085 941 1 786 132 1 040 416 Volume
+0.08% -1.32% +2.15% +0.34% +1.05% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
12/02 | 08:45amPresentation
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 569 M
EBIT 2014 -658 M
Net income 2014 -725 M
Finance 2014 504 M
Yield 2014 -
Sales 2015 1 301 M
EBIT 2015 -8,34 M
Net income 2015 -113 M
Finance 2015 797 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 47,9x
EV / Sales 2015 20,7x
Capitalization 27 754 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
1d ago VERTEX PHARMACEUTICALS : to Present at Deutsche Bank BioFEST on December 2
2d ago VERTEX PHARMACEUTICALS : Assigned Patent
6d ago VERTEX PHARMACEUTICALS : Foundation sells $3.3B in Vertex drug royalties
6d ago NASDAQ 100 MOVERS : Vrtx, adsk
11/20 VERTEX PHARMACEUTICALS : Royalty Pharma pays $3.3 billion for CFF royalty rights..
11/20 VERTEX PHARMACEUTICALS : to Present at Deutsche Bank BioFEST on December 2
11/20 NASDAQ 100 MOVERS : Gmcr, dltr
11/19 VERTEX PHARMACEUTICALS : Studies Conducted at Vertex Pharmaceuticals Inc. on Org..
11/19 VERTEX PHARMACEUTICALS : Foundation sells $3.3B in Vertex drug royalties
11/18 VERTEX PHARMACEUTICALS : U.S. Patents Awarded to Inventors in West Virginia (Nov..
11/18 VERTEX PHARMACEUTICALS : Assigned Patent
11/12 VERTEX PHARMACEUTICALS : Submits Applications in the U.S. and Europe for Approva..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF